Choosing between two strong PR agencies is harder than choosing between a good one and a bad one. JPA Health PR and Hoffman Agency have credible track records, the decision comes down to fit, sector expertise, team chemistry, geographic reach, and strategic alignment.
Both agencies have earned genuine reputations in their respective specialisms, and deserve a fair and independent comparison.
This article examines JPA Health PR and Hoffman Agency PR side by side, their models, their strengths, their limitations, and which type of client each serves best.
JPA Health PR: Background and Core Focus
JPA Health PR is a Washington DC-based agency founded in 1994.
The firm focuses exclusively on health communication, working with healthcare associations, nonprofits, pharmaceutical companies, federal health agencies, and wellness brands.
This narrow focus is JPA Health PR‘s greatest strength. Three decades of specialisation in health communication means their team understands FDA messaging guidelines
They also understand public health campaign frameworks, and health media relationships at a depth that generalist agencies cannot match.
JPA Health PR has worked with clients including the American Heart Association, the Centers for Disease Control and Prevention (CDC), and multiple pharmaceutical and medical device companies.
Their service offering includes media relations, health education campaigns, stakeholder communications, digital health PR, and federal government affairs.
The DC location is strategically important. Health policy is often made in Washington.
An agency embedded in that ecosystem has access to political, regulatory, and public health networks that translate directly into client campaign reach.
However, JPA Health PR‘s sharp focus is also a limitation. If your brand operates in technology outside of health, consumer goods, or financial services, this agency is simply not designed for your needs.
For health and wellness brands, though, their depth is rare. Most PR agencies that claim health PR expertise are generalist firms with a health practice attached.
JPA Health PR is the opposite. Health is not a practice, it is their entire business.
JPA Health PR Results
JPA Health PR has demonstrated success in public health behavior change campaigns, a particularly challenging area of communications where measuring impact requires longitudinal data and nuanced metrics.
Their work with federal health agencies indicates a level of trust and methodological rigour that most private-sector clients would find reassuring.
Federal agency engagements undergo significantly more scrutiny than commercial contracts.
Nonetheless, JPA Health PR‘s premium positioning likely means higher pricing than regional health PR boutiques. Clients should request detailed proposals and compare scopes carefully before committing.
Hoffman Agency PR: Profile and Technology PR Expertise
Hoffman Agency PR was founded in 1987 in San Jose, California, the heart of Silicon Valley.
This origin is not incidental. It shaped the agency’s origin and their approach to technology communications.
Today, Hoffman Agency PR operates globally with offices in the United States, Europe, and Asia-Pacific.
They serve B2B and B2C technology companies across hardware, software, semiconductor, and enterprise technology sectors.
According to their PRCA membership documentation, Hoffman Agency PR has worked with technology brands across multiple continents, navigating culturally distinct media landscapes in Japan, Germany, the UK, and Southeast Asia.
This global reach is a genuine differentiator. For technology companies with international expansion plans, Hoffman Agency PR offers a single agency relationship that spans multiple markets.
That eliminates the complexity of managing multiple regional agencies.
Their core services include media relations, product launch PR, analyst relations, executive communications, and content strategy.
In each area, their practice is built specifically for technology audiences.
However, Hoffman Agency PR‘s global structure also carries risk. Global agencies sometimes provide uneven quality across offices.
A strong San Jose team does not automatically mean equally strong support in Seoul or Frankfurt.
Prospective clients targeting specific international markets should ask for evidence of local team capability and media placement history in those regions specifically.
Read Also: Fahlgren Mortine vs Coyne PR: Midwest Public Affairs PR Advantage
Hoffman Agency PR: Independent Reviews and Campaign Evidence
Hoffman Agency PR has a strong body of documented work in B2B technology PR. Their approach centres on what they call “content-powered PR”, generating original research, technical content, and thought leadership as the engine for earned media.
This mirrors the model used successfully by Walker Sands and other leading B2B tech PR agencies.
Research-led campaigns give technology companies a steady supply of newsworthy content that journalists in tech media actively seek.
On Clutch, Hoffman Agency PR holds a 4.6 out of 5 rating from verified client reviews. Reviewers highlight the agency’s strong writing capabilities, proactive communication, and deep technology sector knowledge.
This feedback echoes a structural challenge common to agencies serving global clients simultaneously. Account teams juggling multiple time zones and media cycles face real capacity constraints.
Consequently, prospective clients of Hoffman Agency PR should negotiate account team allocation and availability explicitly in their contract terms.
Capacity clarity at the start of the relationship prevents frustration later.
How JPA Health PR and Hoffman Agency PR Differ
This direct comparison highlights the core differences between JPA Health PR and Hoffman Agency PR.
- Sector Focus — JPA Health PR is exclusively health; Hoffman covers broad B2B technology
- Geography — JPA anchored in Washington DC; Hoffman operates globally across US, Europe, APAC
- Client Type — JPA serves health nonprofits, federal agencies, and pharmaceutical firms; Hoffman serves hardware, software, and enterprise tech companies
- Campaign Approach — JPA excels in behavior change, public health education, and policy communications; Hoffman specialises in product launch, analyst relations, and content-powered PR
- Media Relationships — JPA’s strongest relationships are in health and science journalism; Hoffman’s are in technology trade and business media
- Team Structure — JPA is a focused boutique; Hoffman is a multi-office global firm
Neither agency is inherently better. They serve fundamentally different client needs.
Moreover, the choice between JPA Health PR and Hoffman Agency PR is rarely a direct competition. A pharmaceutical company would likely not compare these two agencies.
A health technology company, however, might, particularly if their communications challenge spans both health education and technology media.
For health tech companies, the decision depends on where the primary communications challenge sits.
If health policy engagement and public health credibility matter most, JPA Health PR is the stronger choice.
If technology media reach and global PR execution are the priorities, Hoffman Agency PR has the edge.
Pricing Comparison: JPA Health PR vs Hoffman Agency PR
Pricing transparency in both agencies is limited. However, based on comparable agency data and industry benchmarks:
For JPA Health PR:
- Monthly retainer estimates: $8,000–$20,000 for mid-size health organisations
- Federal agency and large nonprofit engagements: Often structured as project or campaign fees, commonly $50,000–$200,000+ for multi-year contracts
- Smaller health campaign projects: Starting around $10,000
For Hoffman Agency PR:
- Monthly retainer estimates: $10,000–$30,000 for B2B tech companies
- International campaign packages: Pricing increases significantly for multi-market support
- Product launch projects: Typically $25,000–$75,000 depending on scope and markets
These estimates draw from PRSA industry benchmarking data and comparable agency profiles on Clutch and Agency Spotter.
Importantly, cost should never be the primary decision factor in selecting a PR agency.
The right question is: what is the expected return on this investment?
A $15,000 monthly retainer that generates consistent tier-1 health media coverage for a pharmaceutical company may represent exceptional value.
A $10,000 retainer from an agency without genuine sector expertise rarely does.
Request detailed proposals from both agencies. Compare not just price but deliverables, team seniority, reporting structure, and reference contacts.
Operational experience
A fair comparison of JPA Health PR and Hoffman Agency PR requires understanding not just what they deliver, but how they work on a daily basis.
Agencies with similar reputations can feel very different once an engagement begins. JPA Health PR tends to operate with the discipline of a health communications consultancy.
Their onboarding process is methodical, often involving a detailed review of regulatory considerations, stakeholder mapping, and message compliance checks.
Clients frequently describe their teams as steady, predictable, and highly attentive to nuance.
The benefit of this approach is clear: when dealing with clinical data, federal policy, or risk‑sensitive audiences, precision matters more than speed.
The trade‑off is that JPA’s processes can feel formal and research-heavy for clients used to faster-moving consumer or tech media cycles.
By contrast, Hoffman Agency PR works with the tempo of a global technology communications firm. Their onboarding typically prioritizes narrative development, product immersion, and rapid pitch testing.
Clients describe them as proactive, high-energy, and strongly oriented toward momentum. In fast‑moving categories like software, semiconductors, and enterprise technology, this pace aligns well with product launch calendars and news cycles.
However, the global structure introduces operational variability.
Different offices may have different strengths, and teams working across time zones can experience bandwidth pressure during peak campaign periods.
In essence, JPA offers depth, deliberation, and regulatory assurance, while Hoffman delivers velocity, global coordination, and strong executional intensity.
Understanding your internal culture and how you prefer to collaborate is a critical part of choosing the right partner.
Strategic Approach Comparison: How Each Agency Thinks and Builds Campaigns
Another missing dimension in evaluating JPA Health PR and Hoffman Agency PR is how they approach strategy and creative development.
JPA’s strategic thinking comes from its roots in health policy, public health communication, and scientific messaging.
When developing campaigns, they often begin with behavioural insights, epidemiological trends, or stakeholder influence mapping.
Their teams are trained to craft messages that withstand regulatory scrutiny, resonate with patient or caregiver communities, and address public health outcomes rather than short-term publicity gains.
This makes JPA especially strong in campaigns where credibility, evidence, and trust are the primary levers of influence.
They excel when the communications challenge involves education, advocacy, or mobilizing hard‑to‑reach health populations.
Hoffman Agency PR, on the other hand, builds strategy with a distinctly technology‑driven mindset. Their approach relies heavily on content-engineering, industry research, and journalist demand signals.
They prioritize framing a company’s narrative in a way that aligns with market dynamics, analyst conversations, and product category shifts.
Their creative development often centers on generating technically credible but media-friendly storylines, ranging from research reports to thought leadership frameworks that help clients break through crowded tech narratives.
For companies that need to demonstrate innovation, differentiation, or technical depth, this style of strategy is highly effective.
The contrast is meaningful: JPA builds campaigns that persuade through public health authority and social impact, while Hoffman builds campaigns that persuade through innovation storytelling and market relevance.
A health tech company, for example, must decide whether its communications challenge is fundamentally about establishing trust as a health organization or standing out as a technology innovator.
The answer determines which agency’s strategic philosophy will serve them better.
Which Agency Should You Choose?
After this full comparison of JPA Health PR and Hoffman Agency PR, the answer depends entirely on your specific brief.
Choose JPA Health PR if:
- Your organisation operates in health, wellness, pharmaceutical, or public health sectors
- Washington DC policy relationships are strategically important
- You need a team with genuine health sector credibility, not a generalist with a health practice
- Your communications challenge involves behaviour change, public health education, or federal agency engagement
Choose Hoffman Agency PR if:
- Your brand operates in B2B or B2C technology
- You need global PR support across multiple markets simultaneously
- Product launches, analyst relations, and technology trade media are your priorities
- You want a research-led content strategy to generate earned media at scale
For health technology companies straddling both worlds, consider which communications challenge is most urgent.
Start there, a single well-executed PR programme outperforms a divided one every time.
Additionally, regardless of which agency you choose, the foundations of a successful relationship are the same: clear brief, realistic expectations, specific KPIs, and senior-level engagement on both sides.
JPA Health PR and Hoffman Agency PR are both credible, experienced agencies.
The better question is not which is better in the abstract, but which is better for you.
Frequently Asked Questions: JPA Health PR vs Hoffman Agency
Q: What does JPA Health PR specialise in?
A: JPA Health PR specialises exclusively in health communications, including media relations for healthcare associations, public health campaigns, pharmaceutical PR, and federal agency communications. Their DC base gives them strong health policy network access.
Q: What does Hoffman Agency PR specialise in?
A: Hoffman Agency PR focuses on B2B and B2C technology communications. They are particularly strong in product launch PR, analyst relations, and international technology media relations across US, European, and Asia-Pacific markets.
Q: Which agency is better for a health tech company?
A: It depends on your primary communications challenge. If health credibility and policy engagement matter most, JPA Health PR is stronger. If technology media reach and global PR execution are the priority, Hoffman Agency PR has the edge.
Q: How much do JPA Health PR and Hoffman Agency charge?
A: Estimated monthly retainers: JPA Health PR ranges from $8,000–$20,000. Hoffman Agency PR ranges from $10,000–$30,000, with international campaigns adding significantly to cost. Neither publishes pricing publicly.
Q: Are there other agencies worth comparing to JPA Health and Hoffman?
A: Yes. W2O Group, GYMR, and Spectrum Group Washington are worth considering for health PR. For technology PR, Walker Sands, Matter Communications, and Highwire PR are comparable alternatives to Hoffman.
Final Verdict: Both Strong, But Built for Different Clients
JPA Health PR and Hoffman Agency PR represent two distinct models of specialist agency excellence.
JPA Health PR wins on health sector depth, DC policy access, and trust within government and nonprofit health communities.
Hoffman Agency PR wins on technology sector breadth, global reach, and content-powered media strategy for B2B and B2C tech brands.
Neither is universally superior. Both deserve serious consideration within their respective specialisms.
The smartest move any brand can make is to be honest about what it actually needs. Match that need to the agency that genuinely delivers it. And then hold that agency accountable with clear metrics from day one.
That is how the best PR partnerships start. And that is how they deliver real results